SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

Not specified

Conditions
Meningitis, CryptococcalHIV Infections
Interventions
DRUG

SCH 39304

Trial Locations (28)

10003

Beth Israel Med Ctr, New York

10029

Mount Sinai Med Ctr, New York

10468

Bronx Veterans Administration / Mount Sinai Hosp, The Bronx

14215

Erie County Med Ctr, Buffalo

14642

Univ of Rochester Medical Center, Rochester

19107

Buckley Braffman Stern Med Associates, Philadelphia

20037

George Washington Univ Med Ctr, Washington D.C.

23219

Richmond AIDS Consortium, Richmond

27710

Duke Univ Med Ctr, Durham

29169

Julio Arroyo, West Columbia

30303

Emory Univ School of Medicine, Atlanta

30912

Med College of Georgia, Augusta

35233

Birmingham Veterans Administration Med Ctr, Birmingham

43210

Ohio State Univ Med Ctr, Columbus

44106

Univ Hosp of Cleveland / Case Western Reserve Univ, Cleveland

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

63112

St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis

70112

Tulane Univ School of Medicine, New Orleans

77030

Houston Veterans Administration Med Ctr, Houston

Univ TX Health Science Ctr, Houston

78284

Audie L Murphy Veterans Administration Hosp, San Antonio

90033

Dr Robert Larsen, Los Angeles

275997215

Univ of North Carolina, Chapel Hill

452670405

Holmes Hosp / Univ of Cincinnati Med Ctr, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

921036325

Univ of California / San Diego Treatment Ctr, San Diego

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

02118

Univ Hosp, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH